Lipidomic Profiling Reveals Distinct Molecular Signatures Across Clinical Subtypes of Myasthenia Gravis
Serum lipidomics revealed subtype-specific metabolic features of MG, with stable disease-associated remodeling and dynamic sphingolipid changes potentially reflecting disease activity, and supports lipidomics as a complementary tool for precision diagnosis and disease stratification, particularly in antibody-negative dsNMG.